Joe Birkett
CEO, TeloNostiX


TeloNostiX is a Cardiff University spin out company with proprietary analytical technology based on the analysis of telomere length and the technology has been fully developed for clinical applications in cancer. The company is trading with several ongoing fee for service contracts with large to mid-size pharmaceutical companies.

Matchmaking Information

Processing. Please wait.